BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Huber S, Kappos L, Fuhr P, Wetzel S, Steck AJ. Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for
hepatitis A and infection with Campylobacter jejuni [letter]. J.Neurol. 1999;1204­6.
Hull HF, Tangermann RH, Aylward RB, Andrus JK. Eradication of poliomyelitis [letter]. Lancet 1999;1910.
Hutchins SS, Rosenthal J, Eason P, Swint E, Guerrero H, Hadler S. Effectiveness and cost­effectiveness of linking the special supplemental program for
women, infants, and children (WIC) and immunization activities. J.Public Health Policy 1999;408­26.
Hutchison BG, Oxman AD, Shannon HS, Lloyd S, Altmayer CA, Thomas K. Clinical effectiveness of pneumococcal vaccine. Meta­analysis [see comments].
Can.Fam.Physician 1999;2381­93.
Huth MM. Children's responses to immunizations: lullabies as distraction. J Child Fam Nurs 1999 Nov­1999 Dec 31;2(6):432­3.
Hutton J, Iglesias C, Jefferson TO. Assessing the potential cost effectiveness of pneumococcal vaccines in the US: methodological issues and current evidence.
Drugs Aging 1999; 15 Suppl 1:31­36.
Ishikawa T, Ogino C, Chang S. Lennox­Gastaut syndrome after a further attenuated live measles vaccination. Brain Dev 1999 Dec;21(8):563­5.
Jacobson SH, Sewell EC, Deuson R, Weniger BG. An integer programming model for vaccine procurement and delivery for childhood immunization: a pilot
study. Health Care Manag Sci 1999 Jan;2(1):1­9.
Jaffar S, Leach A, Hall AJ, Obaro S, McAdam KP, Smith PG, Greenwood BM. Preparation for a pneumococcal vaccine trial in The Gambia: individual or
community randomisation? Vaccine 1999;633­40.
Jain R, Kumar TA, Singh S. Polio eradication in India: are we on the correct path? [letter]. Natl Med J India 1999; 12(6):299­300.
Jain, S.; Chopra, H.; Singh, J. V., et al. Need for strengthening immunization services in villages [letter]. Indian Pediatr 1999 Jun;36(6):619.
Janes GR, Blackman DK, Bolen JC, Kamimoto LA, Rhodes L, Caplan LS, Nadel MR, Tomar SL, Lando JF, Greby SM, Singleton JA, Strikas RA, Wooten
KG. Surveillance for use of preventive health­care services by older adults, 1995­1997. Mor Mortal.Wkly.Rep.CDC Surveill Summ. 1999;51­88.
Jenders RA, Dasgupta B, Mercedes D, Fries F, Stambaugh K. Use of a hospital practice management system to provide initial data for a pediatric
immunization registry. Proc.AMIA.Symp. 1999;286­90.
Jochmus I, Schafer K, Faath S, Muller M, Gissmann L. Chimeric virus­like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and
therapeutic vaccine. Arch.Med.Res. 1999;269­74.
Johnston LJ, Horning SJ. Autologous hematopoietic cell transplantation in non­Hodgkin's lymphoma. Hematol.Oncol.Clin.North Am. 1999;889­918.
Kabakus N, Aydinoglu H, Bakkaloglu SA, Yekeler H. Mumps interstitial nephritis: a case report. Pediatr.Nephrol. 1999;930­1.
Kaithamana S. Fan J. Osuga Y. Liang S. Prabhakar BS. Induction of Experimental Autoimmune Graves’ Disease in BALB/c Mice. The Journal of
Immunology, 1999, 163: 5157­5164.
Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A, Legocki AB. A plant­derived edible
vaccine against hepatitis B virus. FASEB J. 1999;1796­9.
Kato H, Nakata K, Hamasaki K, Hida D, Ishikawa H, Aritomi T, Nakao K, Kato Y, Yano M, Eguchi K. Long­term efficacy of immunization against hepatitis
B virus in infants at high­risk analyzed by polymerase chain reaction. Vaccine 1999;581­7.
Kaufmann SH, Fensterle J, Hess J. The need for a novel generation of vaccines. Immunobiology 1999;272­82.
Keitel WA. Cellular and acellular pertussis vaccines in adults. Clin.Infect.Dis. 1999;S118­S123.
Kerse NM, Flicker L, Jolley D, Arroll B, Young D. Improving the health behaviours of elderly people: randomised controlled trial of a general practice
education programme. BMJ 1999;683­7.
Keywords: Dental Care for Chronically Ill/ Dentistry/ Diagnosis/ Disease Transmission/
Kieseier BC, Archelos JJ, Storch M, Gold R, Hartung HP. The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for
future therapy. Wien.Klin.Wochenschr. 1999;728­37.
Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics­­a novel approach in the management of food allergy. Allergy 1999;909­15.
Knutson KL, Schiffman K, Rinn K, Disis ML. Immunotherapeutic approaches for the treatment of breast cancer. J Mammary Gland Biol Neoplasia 1999;
4(4):353­365.
Kossaczka Z, Lin FY, Ho VA, Thuy NT, Van Bay P, Thanh TC, Khiem HB, Trach DD, Karpas A, Hunt S, Bryla DA, Schneerson R, Robbins JB, Szu SC.
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2­ to 4­year­old children in Vietnam. Infect.Immun.
1999;5806­10.
Kotra LP, Ojcius DM. 'Infectious web'. Microbes.Infect. 1999;1239.
Kozlowski J. This month in investigative urology: Immunotherapy of bladder cancer [comment]. J.Urol. 1999;1581.
Krcmery V, Gould IM. Antibiotic policies in Central/ Eastern Europe (CEE) after 1990. J.Hosp.Infect. 1999;S269­S274.
Krieg AM. Direct immunologic activities of CpG DNA and implications for gene therapy. J Gene Med 1999; 1(1):56­63.
Kristensen K. Haemophilus influenzae type b. Epidemiology of invasive diseases, antimicrobial resistance of clinical isolates, and response to a conjugate
vaccine in selected risk groups. Dan.Med.Bull. 1999;303­12.
Kyaw MH, Nguyen­Van­Tam JS, Pearson JC. Family doctor advice is the main determinant of pneumococcal vaccine uptake. J.Epidemiol.Community Health
1999;589­90.
Lalumiere ML, Harris GT, Rice ME. Birth order and fluctuating asymmetry: a first look. Proc.R.Soc.Lond B Biol.Sci. 1999;2351­4.
Lang J, Wood SC. Development of orphan vaccines: an industry perspective. Emerg.Infect.Dis. 1999;749­56.
Le Hello C, Cohen P, Bousser MG, Letellier P, Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol 1999 Jan;26(1):191­4.
Le Hello C, Cohen P, Bousser MG, Letellier P, Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol 1999 Jan;26(1):191­4.
LeDuc JW, Becher J. Current status of smallpox vaccine [letter]. Emerg.Infect.Dis. 1999;593­4.
Lee A, Cheng F, Lau L, Lo A, Fabb WE. Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: what are the implications? Public
Health 1999;185­8.
Lee LH, Burg E, III, Baqar S, Bourgeois AL, Burr DH, Ewing CP, Trust TJ, Guerry P. Evaluation of a truncated recombinant flagellin subunit vaccine against
Campylobacter jejuni. Infect.Immun. 1999;5799­805.
Legge A. Killer in the house. Nurs Times Nurs Homes 1999 Nov­1999 Dec 31;1(4):7.
Legge A. Nurses will face challenge of meningitis campaign [news]. Community Nurse 1999; 5(8):13­14.
Leggiadro RJ, Schaberg DR. Nosocomial pneumococcal infection: an outbreak. Hosp Pract 1999 Sep 15;34(10):77­8, 81­2, 86­92.
Lehmann D, Michael A, Omena M, Clegg A, Lupiwa T, Sanders RC, Marjen B, Wai'in P, Rongap A, Saleu G, Namuigi P, Kakazo M, Lupiwa S, Lewis DJ,
Alpers MP. Bacterial and viral etiology of severe infection in children less than three months old in the highlands of Papua New Guinea. Pediatr.Infect.Dis.J.
1999;S42­S49.
Liashenko VA, Krasnova VP, Youminova NV. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles
vaccine L­16. Hum Antibodies 1999; 9(3):143­148.
Lifson AR, Aitchison­Olson R, Ramesh A. New threats from an old enemy. A physician update on pneumococcus. Minn.Med. 1999;29­31.
Lindberg J, Fangel S. Recurrent endocarditis caused by Streptococcus pneumoniae. Scand.J.Infect.Dis. 1999;409­10.
Linder N, Raz M, Sirota L, Reichman B, Lubin D, Kuint J, Cohen AH, Barzilai A. Unexplained fever in neonates may be associated with hepatitis B vaccine.
Arch.Dis.Child Fetal Neonatal Ed 1999;F206­F207.
Lindfors A, Hage­Hamsten M, Rietz H, Wickman M, Nordvall SL. Influence of interaction of environmental risk factors and sensitization in young asthmatic
children. J.Allergy Clin.Immunol. 1999;755­62.
Liu MA. Vaccines timeline [interview by Philip Cohen]. BMJ 1999;1301.